TABLE 1.
Baseline characteristics at SLKT
| Variables at LT (N = 570) | Median (IQR) or N (%) |
|---|---|
| Recipient characteristics | |
| Age at transplant | 58 (51–64) |
| Male | 361 (63%) |
| Race White Black Other | 432 (75%)71 (12%)67 (12%) |
| Etiology of liver disease Hepatitis C Alcohol NASH/cryptogenic cirrhosis Other | 189 (33%)131 (23%)112 (20%)138 (24%) |
| Status at transplant ICU Ambulatory Hospital floor | 329 (58%)166 (29%)74 (13%) |
| Renal replacement therapy at liver transplant | 220 (39%) |
| Medical comorbidities at transplant Hypertension Diabetes Body mass index Renal risk index MELD-Na | 306 (54%)237 (42%)27 (24–32)7.57 (5.2–12.2)28 (23–34) |
| Donor and transplant characteristics | |
| Donor age (y) Donation after circulatory death Donor sex (male gender) Cause of death: cerebrovascular KDPI (N = 184) |
36 (23–48)24 (4%)318 (56%)382 (67%)32% (15%–66%) |
| Cold ischemia time (min) Warm ischemia time (min) | 360 (300–465)37.5 (25–60) |
| Immunosuppression Induction Tacrolimus Cyclosporine | 138 (24%)541 (95%)29 (5%) |
ICU, intensive care unit; IQR, interquartile range; KDPI, Kidney Donor Profile Index; LT, liver transplant; MELD-Na, model for end stage liver disease-sodium; NASH, nonalcoholic steatohepatitis.